SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide

被引:81
作者
Sly, LM [1 ]
Rauh, MJ [1 ]
Kalesnikoff, J [1 ]
Buchse, T [1 ]
Krystal, G [1 ]
机构
[1] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
关键词
D O I
10.1016/j.exphem.2003.09.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The phosphatidylinositol-3 kinase (PI3K) pathway plays a central role in regulating numerous biologic processes, including survival, adhesion, migration, metabolic activity, proliferation, differentiation, and end cell activation through the generation of the potent second messenger PI-3,4,5-trisphosphate (PI-3,4,5-P-3). To ensure that activation of this pathway is appropriately suppressed/terminated, the ubiquitously expressed 54-kDa tumor suppressor PTEN hydrolyzes PI-3,4,5-P-3 to PI-4,5-P-2, whereas the 145-kDa hematopoietic-restricted SH2-containing inositol 5'-phosphatase SHIP (also known as SHIP1), the 104-kDa stem cell-restricted SHIP sSHIP, and the more widely expressed 150-kDa SHIP2 break it down to PI-3,4-P-2. In this review, we focus on the properties of these phospholipid phosphatases and summarize recent data showing that the activities of these negative regulators often are modulated by simply altering their protein levels. We also highlight the critical role that SHIP plays in lipopolysaccharide-induced macrophage activation and in endotoxin tolerance. (C) 2003 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:1170 / 1181
页数:12
相关论文
共 146 条
  • [21] Ebert MPA, 2002, BRIT J CANCER, V86, P257, DOI 10.1038/sj/bjc/6600031
  • [22] Activation of PPARγ increases PTEN expression in pancreatic cancer cells
    Farrow, B
    Evers, BM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (01) : 50 - 53
  • [23] Overexpression of the inositol phosphatase SopB in human 293 cells stimulates cellular chloride influx and inhibits nuclear mRNA export
    Feng, YC
    Wente, SR
    Majerus, PW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (03) : 875 - 879
  • [24] IKKε and TBK1 are essential components of the IRF3 signaling pathway
    Fitzgerald, KA
    McWhirter, SM
    Faia, KL
    Rowe, DC
    Latz, E
    Golenbock, DT
    Coyle, AJ
    Liao, SM
    Maniatis, T
    [J]. NATURE IMMUNOLOGY, 2003, 4 (05) : 491 - 496
  • [25] Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
    Fitzgerald, KA
    Palsson-McDermott, EM
    Bowie, AG
    Jefferies, CA
    Mansell, AS
    Brady, G
    Brint, E
    Dunne, A
    Gray, P
    Harte, MT
    McMurray, D
    Smith, DE
    Sims, JE
    Bird, TA
    O'Neill, LAJ
    [J]. NATURE, 2001, 413 (6851) : 78 - 83
  • [26] Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1
    Fox, JA
    Ung, K
    Tanlimco, SG
    Jirik, FR
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (01) : 49 - 54
  • [27] PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms
    Freeman, DJ
    Li, AG
    Wei, G
    Li, HH
    Kertesz, N
    Lesche, R
    Whale, AD
    Martinez-Diaz, H
    Rozengurt, N
    Cardiff, RD
    Liu, X
    Wu, H
    [J]. CANCER CELL, 2003, 3 (02) : 117 - 130
  • [28] SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells
    Galandrini, R
    Tassi, F
    Mattia, G
    Lenti, L
    Piccoli, M
    Frati, L
    Santoni, A
    [J]. BLOOD, 2002, 100 (13) : 4581 - 4589
  • [29] Galandrini R, 2001, EUR J IMMUNOL, V31, P2016, DOI 10.1002/1521-4141(200107)31:7<2016::AID-IMMU2016>3.0.CO
  • [30] 2-W